A detailed history of Vanguard Group Inc transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,099,956 shares of ACET stock, worth $4.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,099,956
Previous 3,126,578 0.85%
Holding current value
$4.03 Million
Previous $7.35 Million 48.96%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.21 - $2.4 $32,212 - $63,892
-26,622 Reduced 0.85%
3,099,956 $3.75 Million
Q1 2024

May 10, 2024

BUY
$1.76 - $3.45 $2.54 Million - $4.97 Million
1,441,503 Added 85.55%
3,126,578 $7.35 Million
Q4 2023

Feb 14, 2024

BUY
$1.11 - $1.89 $14,084 - $23,982
12,689 Added 0.76%
1,685,075 $3.18 Million
Q3 2023

Nov 14, 2023

BUY
$1.37 - $3.4 $5,069 - $12,580
3,700 Added 0.22%
1,672,386 $2.29 Million
Q2 2023

Aug 14, 2023

SELL
$2.13 - $7.13 $46,397 - $155,312
-21,783 Reduced 1.29%
1,668,686 $4.05 Million
Q1 2023

May 15, 2023

SELL
$5.52 - $9.23 $3,438 - $5,750
-623 Reduced 0.04%
1,690,469 $9.74 Million
Q4 2022

Feb 10, 2023

BUY
$7.72 - $21.27 $1.48 Million - $4.08 Million
191,833 Added 12.8%
1,691,092 $15.1 Million
Q3 2022

Nov 14, 2022

BUY
$13.43 - $18.74 $3.55 Million - $4.95 Million
264,049 Added 21.38%
1,499,259 $21.3 Million
Q2 2022

Aug 12, 2022

BUY
$10.26 - $20.81 $1.68 Million - $3.4 Million
163,555 Added 15.26%
1,235,210 $18 Million
Q1 2022

May 13, 2022

SELL
$11.53 - $19.97 $2.02 Million - $3.5 Million
-175,478 Reduced 14.07%
1,071,655 $21.4 Million
Q4 2021

Feb 14, 2022

BUY
$7.37 - $17.49 $1.33 Million - $3.15 Million
180,314 Added 16.9%
1,247,133 $21.8 Million
Q3 2021

Nov 12, 2021

BUY
$6.29 - $9.93 $37,727 - $59,560
5,998 Added 0.57%
1,066,819 $8.36 Million
Q2 2021

Aug 13, 2021

BUY
$9.19 - $15.93 $9.75 Million - $16.9 Million
1,060,821 New
1,060,821 $10.9 Million

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $52M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.